company background image
DXRX

Diaceutics AIM:DXRX Stock Report

Last Price

UK£0.76

Market Cap

UK£63.7m

7D

0%

1Y

-25.2%

Updated

02 Dec, 2022

Data

Company Financials +
DXRX fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends0/6

DXRX Stock Overview

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

Diaceutics PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Diaceutics
Historical stock prices
Current Share PriceUK£0.76
52 Week HighUK£1.22
52 Week LowUK£0.74
Beta0.12
1 Month Change-4.43%
3 Month Change-17.94%
1 Year Change-25.25%
3 Year Change-20.53%
5 Year Changen/a
Change since IPO-20.94%

Recent News & Updates

Recent updates

Estimating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)

Jul 24
Estimating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)

Would Shareholders Who Purchased Diaceutics' (LON:DXRX) Stock Year Be Happy With The Share price Today?

Feb 04
Would Shareholders Who Purchased Diaceutics' (LON:DXRX) Stock Year Be Happy With The Share price Today?

Here's Why We Don't Think Diaceutics's (LON:DXRX) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 31
Here's Why We Don't Think Diaceutics's (LON:DXRX) Statutory Earnings Reflect Its Underlying Earnings Potential

Do Insiders Own Lots Of Shares In Diaceutics PLC (LON:DXRX)?

Nov 27
Do Insiders Own Lots Of Shares In Diaceutics PLC (LON:DXRX)?

Shareholder Returns

DXRXGB Life SciencesGB Market
7D0%-0.3%1.0%
1Y-25.2%-52.8%-6.0%

Return vs Industry: DXRX exceeded the UK Life Sciences industry which returned -52.8% over the past year.

Return vs Market: DXRX underperformed the UK Market which returned -6% over the past year.

Price Volatility

Is DXRX's price volatile compared to industry and market?
DXRX volatility
DXRX Average Weekly Movement2.3%
Life Sciences Industry Average Movement8.4%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.1%
10% least volatile stocks in GB Market2.8%

Stable Share Price: DXRX is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: DXRX's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005133Peter Keelinghttps://www.diaceutics.com

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks.

Diaceutics PLC Fundamentals Summary

How do Diaceutics's earnings and revenue compare to its market cap?
DXRX fundamental statistics
Market CapUK£63.68m
Earnings (TTM)UK£129.00k
Revenue (TTM)UK£15.51m

496.7x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DXRX income statement (TTM)
RevenueUK£15.51m
Cost of RevenueUK£4.05m
Gross ProfitUK£11.46m
Other ExpensesUK£11.33m
EarningsUK£129.00k

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.0015
Gross Margin73.91%
Net Profit Margin0.83%
Debt/Equity Ratio0%

How did DXRX perform over the long term?

See historical performance and comparison